Publications by authors named "Mario Altendorfer"

Claim this Profile
A
A randomized, single-blind, Phase I trial (INVICTAN-1) assessing the bioequivalence and safety of BI 695502, a bevacizumab biosimilar candidate, in healthy subjects.
Willem Hettema, Christopher Wynne, Benjamin Lang, Mario Altendorfer, Niklas Czeloth

Expert Opin Investig Drugs· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioequivalence, safety and immunogenicity of BI 695501, an adalimumab biosimilar candidate, compared with the reference biologic in a randomized, double-blind, active comparator phase I clinical study (VOLTAIRE®-PK) in healthy subjects.
Christopher Wynne, Mario Altendorfer, Ivo Sonderegger, Lien Gheyle, Rod Ellis-Pegler

Expert Opin Investig Drugs· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modular synthesis of polyene side chain analogues of the potent macrolide antibiotic etnangien by a flexible coupling strategy based on hetero-bis-metallated alkenes.
Mario Altendorfer, Aruna Raja, Florenz Sasse, Herbert Irschik, Dirk Menche

Org Biomol Chem· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and biological evaluation of simplified side chains of the macrolide antibiotic etnangien.
Mario Altendorfer, Herbert Irschik, Dirk Menche

Bioorg Med Chem Lett· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficient synthesis of diverse hetero-bis-metallated alkenes as modular reagents towards highly conjugated and isolated olefinic systems.
Mario Altendorfer, Dirk Menche

Chem Commun (Camb)· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis